Introduction
============

Colonoscopy has been widely accepted as a highly effective tool to decrease mortality of colorectal cancer [@JR1510-1] [@JR1510-2] [@JR1510-3] [@JR1510-4] [@JR1510-5] . To best achieve the clinical goal of reduced mortality, all neoplasms should be detected during the examination and treated appropriately [@JR1510-6] [@JR1510-7] . However, colonoscopy is not flawless in detection of lesions; there is a substantial risk of missing lesions due to anatomical features, preparation quality, or endoscopists' experience [@JR1510-8] [@JR1510-9] [@JR1510-10] [@JR1510-11] . Moreover, the post-polypectomy surveillance interval is set by findings from the initial colonoscopy, including the number, size, and histological findings of detected lesions [@JR1510-6] [@JR1510-12] . Therefore, it is crucial to detect all neoplastic lesions to determine appropriate long-term management and achieve the ultimate purpose of colon cancer screening.

Several anatomical features contribute to risk of missed lesions. Deep haustral folds and sharp curves are associated with missed lesions. Haustral folds are usually deeper in the proximal than in the distal colon; this is considered to be one of the common causes for missed lesions in the proximal colon. On the other hand, the sigmoid colon is dangling and able to both expand and shrink, like a bellows. Therefore, the sigmoid colon sometimes shows deep folds, and this situation is often seen during the withdrawal phase of colonoscopy. In general, insertion to the cecum should be completed as quickly as possible, and the search for lesions should be conducted during withdrawal [@JR1510-13] . However, deep folds, which can be encountered in the sigmoid colon in the withdrawal phase, make it difficult to detect subtle neoplastic lesions, especially behind the folds. Hence, searching for lesions during insertion is also important for decreasing risk of missed lesions, especially in the sigmoid colon.

Linked color imaging (LCI), a newly developed optical technology, can enhance mucosal surface contrast as compared to that with white light imaging (WLI) due to its optical characteristics [@JR1510-14] [@JR1510-15] [@JR1510-16] . With LCI, extensive observation of the colonic lumen can be obtained and polyp lesions can be detected on the distant view. Thus, LCI might contribute to detection of a greater number of sigmoid colon polyp lesions during insertion compared to that obtained with WLI.

The aim of the current study was to evaluate efficacy and feasibility of insertion-phase LCI in terms of the additional benefit of colorectal polyp detection over that obtained with WLI.

Patients and methods
====================

Study design
------------

This study investigated endoscopic outcomes by retrospective review of medical records.

Patients
--------

Patients who underwent colonoscopy performed by a single, experienced endoscopist at the National Cancer Center Hospital in Tokyo, Japan between November 2017 and June 2018 were considered as candidates for this retrospective study. Patients who were referred for age- and risk-appropriate screening colonoscopy, post-polypectomy surveillance, or endoscopic evaluation of a positive fecal occult blood test were enrolled. Patients with inflammatory bowel disease, polyposis syndrome, and postsurgical colorectal cancer surveillance were excluded.

Endoscopic procedure
--------------------

Following bowel preparation, nurses assessed bowel cleansing and permitted colonoscopy only after achievement of a sufficiently clean state. Quality of bowel preparation during colonoscopy was scored according to the extent of mucosal visualization after suctioning fluid residue, in accordance with the Aronchick Bowel Preparation Scale: excellent (≥ 95 % mucosal visualization), good (90 %-95 % mucosal visualization), fair (80% -- 90 % mucosal visualization), and poor (\< 80 % mucosal visualization).

Colonoscopy was performed using an endoscope system (LL-4450; Fujifilm Co, Tokyo, Japan) and high-definition colonoscope (EC-600ZP, EC-600ZP7; Fujifilm Co, Tokyo, Japan). Use of LCI or WLI during colonoscope insertion, which is not regulated by the Japanese Pharmaceutical Affairs Law, alternated between consecutive patients, at the endoscopist's discretion, during the study period. LCI was performed during withdrawal in all patients. All lesions were photographed immediately after detection, during both insertion and withdrawal. We did not resect any lesions during insertion. Detailed observation, with magnifying blue laser imaging (BLI) or chromoendoscopy, was performed only during withdrawal, if necessary. Lesions diagnosed as an adenoma, high-grade intramucosal neoplasm, or sessile serrated lesion (SSL) were endoscopically removed. The resect-and-discard strategy was allowed for lesions smaller than 5 mm when it was difficult to retrieve the resected specimen. Hyperplastic polyps smaller than 10 mm in the sigmoid to rectosigmoid colon were excluded from analysis. Insertion and pure observation time were recorded for all cases, and time of endoscopic resection was removed from the later measure.

For determination of identical lesions detected during insertion and withdrawal, we evaluated lesion size, macroscopic type, and color and number of lesions in the sigmoid colon by using still images. Location was determined from the splenic flexure finding.

Outcomes
--------

The primary endpoint was proportion of lesions in the sigmoid colon only detected during insertion. Secondary endpoints were mean number of lesions detected in the sigmoid colon per patient. We also defined SSLs as sessile serrated adenomas/polyps (SSA/Ps) and traditional serrated adenomas (TSAs). Adenomas were defined as an adenomatous lesion, with the exception of tubulovillous adenomas (TVAs); TVAs were considered as high-grade intramucosal neoplasms (HGINs) in this study. Index lesions were defined as follows: adenomas ≥ 10 mm, having villous histology; HGINs; cancer; SSLs ≥ 10 mm; or serrated lesions harbouring dysplasia, including TSAs.

Statistical analysis
--------------------

Continuous data are reported as means and 95 % confidence intervals (CIs); categorical data are reported as numbers, rates, and 95 % CIs. Differences in means between LCI and WLI groups were evaluated using mean differences with 95 % CIs. Differences in distribution between LCI and WLI groups were evaluated using the Chi-square test. In addition, proportional odds models were used to explore the relationship between characteristics of detected lesions and group assignment. In this model, the generalized estimating equation (GEE) method was applied to account for correlated observations among lesions. Odds ratios for both the GEE and independent models are reported. Proportional odds models with GEE were performed using SAS release 9.40 software (Cary, North Carolina, United States). Other statistical analyses were performed using EZR software ( <http://www.jichi.ac.jp/saitama-sct/SaitamaHP.files/statmed.html> ) [@JR1510-17] .

Ethics
------

The study was conducted according to guidelines of our Institutional Review Board, which approved this study and waived the requirement for informed consent. Patients were able to opt out of participation on our hospital website. All patients provided written informed consent for undergoing the colonoscopic and endoscopic treatments.

Results
=======

A total of 138 patients were consecutively enrolled, with equal numbers of patients assigned to the LCI and WLI groups. Clinical characteristics and short-term outcomes of the colonoscopy are shown, according to group, in [Table 1](#TB1510-1){ref-type="table"} and [Table 2](#TB1510-2){ref-type="table"} . Baseline patient characteristics of sex, age, body mass index, history of abdominal surgery, indication for colonoscopy, and bowel preparation assessment during examination did not significantly differ between the two groups. Among colonoscopic outcomes, only insertion time statistically differed between the two groups, with a shorter insertion time (by 1 minute) in the LCI group than in the WLI group. 

###### Clinical characteristics according to group.

                                                                     LCI group (n = 69)        WLI group (n = 69)        Difference (95 % CI) or *P* value
  ------------------------------------------------------------------ ------------------------- ------------------------- -----------------------------------
  Sex, male [1](#FN1510-1){ref-type="table-fn"}                      49, 0.71 (0.60 -- 0.81)   45, 0.65 (0.54 -- 0.76)   0.06 (-0.10 -- 0.21)
  Age, years [2](#FN1510-2){ref-type="table-fn"}                     64.2 (61.6 -- 66.8)       65.0 (62.7 -- 67.3)       --0.82 (-4.33 -- 2.68)
  Body mass index, kg/m ^2^ [2](#FN1510-2){ref-type="table-fn"}      23.4 (22.4 -- 24.4)       23.0 (22.2 -- 23.8)       0.44 (-0.85 -- 1.74)
  History of abdominal surgery [1](#FN1510-1){ref-type="table-fn"}   14, 0.20                  15, 0.22                  1
  Indication for colonoscopy [1](#FN1510-1){ref-type="table-fn"}                                                         0.702
  Screening                                                          23, 0.33                  28, 0.41                  
  Surveillance after endoscopic treatment                            31, 0.45                  27, 0.39                  
  Fecal occult blood-positive                                        15, 0.22                  14, 0.20                  
  Bowel preparation [1](#FN1510-1){ref-type="table-fn"}                                                                  1
  Excellent/Good                                                     69, 1.0                   69, 1.0                   
  Fair/Poor                                                          0, 0                      0, 0                      

LCI, linked color imaging; WLI, white light imaging; CI, confidence interval

Data are given as number, rate and 95 % CI

Data are given as mean and 95 % CI

###### Short-term outcomes of colonoscopy according to group.

                                                                       LCI group (n = 69)        WLI group (n = 69)        Difference (95 % CI) or *P* value
  -------------------------------------------------------------------- ------------------------- ------------------------- -----------------------------------
  Cecal intubation [1](#FN1510-3){ref-type="table-fn"}                 69, 1.0 (0.96 -- 1.04)    69, 1.0 (0.96 -- 1.04)    1
  Time to the cecum, minutes [2](#FN1510-4){ref-type="table-fn"}       4.4 (3.9 to 4.9)          5.4 (4.8 to 6.0)          --0.94 (-1.75 to -- 0.13)
  Pure observation time, minutes [2](#FN1510-4){ref-type="table-fn"}   8.5 (8.1 to 8.9)          8.5 (8.2 to 8.8)          --0.03 (-0.55 to 0.50)
  Sedation [1](#FN1510-3){ref-type="table-fn"}                         13, 0.19 (0.10 to 0.28)   13, 0.19 (0.10 to 0.28)   1

LCI, linked color imaging; WLI, white light imaging; CI, confidence interval

Data are given as number, rate and 95 % CI

Data are given as mean and 95 % CI

In the LCI group, 144 lesions were detected in 69 patients. Of these, 134 lesions were resected using cold snare polypectomy (CSP) or cold biopsy (BP); eight lesions were resected by hot snare polypectomy (PO), endoscopic mucosal resection (EMR), or endoscopic submucosal dissection; BP was used to attempt estimation of histology for one submucosal tumor (SMT); and one lesion was treated by surgery due to a diagnosis of deep submucosal invasion. In the WLI group, 132 lesions were detected in 69 patients. Of these, 127 lesions were resected by CSP or BP, and five lesions were treated by PO or EMR. Furthermore, 20 and seven lesions were discarded from the LCI and WLI groups, respectively, after CSP due to size criteria. Procedural and histological characteristics of lesions detected are shown in [Table 3](#TB1510-3){ref-type="table"} . In the independent odds models, lesion size ( *P*  = 0.958), histology ( *P*  = 0.303), and endoscopic diagnosis ( *P*  = 0.914) were not significantly different between the two groups. However, location ( *P*  = 0.027) and morphology ( *P*  = 0.048) were significantly different between the groups. In the proportional odds models with GEE, which accounted for correlated observations, morphology was marginally significant, and location was the only factor that significantly differed between the groups. Odds ratios for both the GEE and independent models are shown in [Table 3](#TB1510-3){ref-type="table"} . In both groups, approximately 70 % of lesions were categorized as diminutive (\< 5 mm), and approximately 20 % of lesions were small (6 -- 9 mm). Regarding endoscopic diagnoses, in both groups, approximately 80 % of lesions were estimated as adenomas, fewer than 10 % were estimated as SSLs, and 2 % to 3 % were estimated as HGINs or cancer. Furthermore, 16 (11 %) and 10 (8 %) lesions were categorized as index lesions in the LCI and WLI groups, respectively.

###### Clinical and histological characteristics of the detected lesions and their relationships with group assignment.

                         LCI group (n = 144)   WLI group (n = 132)   *P* value   Odds ratios   95 % confidence interval   Odds ratios   95 % confidence interval          
  ---------------------- --------------------- --------------------- ----------- ------------- -------------------------- ------------- -------------------------- ------ ----------------
  Lesion size, mm                                                                              0.958                      1.01          (0.63 -- 1.62)             1.01   (0.69 -- 1.48)
  1 -- 5 (reference)     105                   72.9                   96         72.7                                                                                     
  6 -- 9                  27                   18.8                   26         19.7                                                                                     
  10-                     12                    8.3                   10          7.6                                                                                     
  Location                                                                                     0.027                      1.31          (1.04 -- 1.65)             1.31   (1.10 -- 1.56)
  Cecum (reference)        4                    2.8                   13          9.8                                                                                     
  Ascending               31                   21.5                   41         31.1                                                                                     
  Transverse              48                   33.3                   41         31.1                                                                                     
  Descending               6                    4.2                    4          3.0                                                                                     
  Sigmoid-rectosigmoid    49                   34.0                   28         21.2                                                                                     
  Rectum                   6                    4.2                    5          3.8                                                                                     
  Morphology                                                                                   0.048                      1.86          (0.90 -- 3.82)             1.86   (1.07 -- 3.24)
  Polypoid (reference)    27                   18.8                   39         29.5                                                                                     
  Non-polypoid           116                   80.6                   93         70.5                                                                                     
  SMT                      1                    0.7                    0          0.0                                                                                     
  Histology                                                                                    0.303                      1.01          (0.77 -- 1.31)             1.01   (0.81 -- 1.25)
  Adenoma (reference)     82                   56.9                   91         68.9                                                                                     
  HGIN, cancer             7                    4.9                    2          1.5                                                                                     
  SSLs                    10                    6.9                    8          6.1                                                                                     
  Non-neoplastic          17                   11.8                   21         15.9                                                                                     
  Endoscopic diagnosis                                                                         0.914                      0.99          (0.69 -- 1.41)             0.99   (0.76 -- 1.28)
  Adenoma (reference)    120                   83.3                  110         83.3                                                                                     
  HGIN, cancer             4                    2.8                    2          1.5                                                                                     
  SSLs                    11                    7.6                   11          8.3                                                                                     
  Non-neoplastic           8                    5.6                    9          6.8                                                                                     
  SMT                      1                    0.7                    0          0.0                                                                                     

Data are given as numbers and rates

LCI, linked color imaging; WLI, white light imaging; GEE, generalized estimating equation; HGIN, high-grade intramucosal neoplasm; SSL, sessile serrated lesion; SMT, submucosal tumor.

Proportional odds models were used to explore the relationship between the characteristics of detected lesions and group assignment. The GEE method was used to account for correlated observations among lesions.

Most lesions located in proximal colon were detected during withdrawal, with no significant difference in proportion between the LCI and WLI groups ( [Fig. 1](#FI1510-1){ref-type="fig"} ). It is of note that lesions located in the sigmoid and rectosigmoid colon showed a different pattern of results. Specifically, in the LCI group, eight of 49 lesions (16 %) could only be detected during insertion, and no such lesions (0 %) were detected during insertion in the WLI group ( *P*  = 0.045). In these cases, we reinserted the colonoscope back to the sigmoid colon; seven of eight lesions could be re-detected. Only one lesion which was diagnosed as a diminutive adenoma could not be detected again. [Fig. 2](#FI1510-2){ref-type="fig"} shows a representative case in which we were able to detect the lesion only during insertion.

![Relationship between location of detected lesion and phase in which lesion was detected. LCI, linked colour imaging; WLI, white light imaging](10-1055-a-0982-2904-i1510ei1){#FI1510-1}

![representative case showing a lesion missed during the withdrawal phase. **a, b, c** Three lesions were detected in order during the insertion phase. **c, d, e** Only two lesions were detected during the withdrawal phase. The lesions in **a** and **e** , and **c** and **d** were judged to reflect the same lesion by comparing the size and morphology. The lesion in **b** could not be identified during withdrawal but was detected by reinsertion after observation of the rectum.](10-1055-a-0982-2904-i1510ei2){#FI1510-2}

Discussion
==========

Results of the current study suggest that LCI improves detection of colorectal polyp lesions during insertion phase, especially in the sigmoid colon.

Detection of colorectal lesions is generally attempted during withdrawal, and insertion phase is usually devoted to reaching the cecum as quickly and safely as possible. Therefore, appropriate colorectal polyp detection has been evaluated during withdrawal. There are two published randomized controlled studies on efficacy of LCI for detection of colorectal lesions: Min at el. [@JR1510-18] reported its efficacy in a randomized crossover trial, and Paggi et al. [@JR1510-19] reported its efficacy in a randomized tandem colonoscopy study. The former study demonstrated that LCI improved detection of not only polyps but also adenomas, and the latter study demonstrated that LCI reduced the possibility of missing a lesion in the right colon. Both studies appear to have evaluated the number of polyps detected during withdrawal phase.

We have experienced cases in which we could not re-find polyps located in the sigmoid colon that were initially detected during insertion. Therefore, we intended to evaluate efficacy of LCI during insertion phase for detection of colorectal lesions located in the sigmoid colon. We found that approximately 10 % of lesions in the sigmoid colon could only be detected during insertion. Moreover, this superior detectability during the insertion phase was demonstrated in the LCI group but not in the WLI group. This result suggests the clinical utility of LCI in addition to conventional colonoscopy. It is of note that insertion time was shorter in the LCI group than in the WLI group; however, the actual difference was 1 minute. From these results, applying LCI during insertion might be recommended. One potential issue with LCI is that halation due to its strong brightness conversely worsens the visibility of the lumen, and some endoscopists might feel discomfort due to a lack of experience. However, one can immediately and easily change the light mode from LCI to WLI with the push of a single button.

In this study, we could not prove the efficacy of LCI for advanced polyps, detection of which is also considered to be important for prevention colorectal cancer mortality. In the current study, most of the detected lesions were diagnosed as tubular adenomas smaller than 5 mm, and the overall percentage of advanced polyps was 10 %. Several factors may explain this result. Given the indications for the current study, more than half the patients were likely categorized as average risk for colorectal cancer. In addition, the patients who were undergoing surveillance after endoscopic treatment should have already had most of their advanced polyps resected on prior colonoscopy within the past 5 years. It is conceivable that advanced polyps larger than 10 mm would be detected more easily than diminutive polyps, and it is difficult to prove the additional benefit of LCI to currently available imaging modalities for detection of such advanced neoplastic polyps. The current study was intended to evaluate LCI's overall detection ability. We think the ability to detect diminutive polyps, which are more difficult to detect than larger lesions, should more precisely determine use of the technology.

The current study results demonstrated that more attention should be paid to the features of missed lesions located in the sigmoid colon. Most of the lesions located in the right colon could be detected during withdrawal. In contrast, fewer than 30 % of lesions in the WLI group could be recognized during both insertion and withdrawal, and fewer than 70 % of lesions in the LCI group could be recognized during both insertion and withdrawal. Moreover, approximately 10 % of lesions could only be detected during insertion. This result might reflect a unique feature of sigmoid colon lesions. In general, one of the causes for missed lesions is thought to be existence of a blind spot due to a sharp curvature or deep fold, and the right colon is the part of the colon where we often encounter missed lesions. Generally, the easiest way to overcome this issue is to perform a detailed observation using retroflexion. However, retroflexion is difficult in the sigmoid colon, as it easily expands and contracts. Hence, detection during both insertion and withdrawal is thought to be crucial to decrease incidence of missed lesions in the sigmoid colon.

The current study has some limitations. First, it was not designed as a prospective randomized study, and was conducted at a single institution, with a limited number of cases. Namely, it is impossible to exclude the effect of confounding biases in the comparisons of outcomes. Thus, a larger-scale prospective study should be conducted to validate the results of this observational study. The current results can be used to determine the appropriate sample size for a future trial. Second, perfect identification of lesions detected during both insertion and withdrawal, or in just one phase, was difficult in this study. However, marking lesions for resection during insertion could further aid in identifying lesions detected in both or one phase. Moreover, such methodology is not recognized as general procedure, but we consider that the current method of identifying lesions detected in both/one phase is the currently the best possible manner, even though it was not perfect. Third, the current study results are based on clinical outcomes of a colonoscopy performed by an experienced endoscopist. Efficacy of insertion-phase LCI should be confirmed in a larger number of endoscopists, ideally including endoscopists with variable expertise. We plan to overcome these issues in a future validity study. Fourth, it was difficult to evaluate efficacy of insertion-phase LCI for detection of advanced adenomas because of their low prevalence in the study population. Thus, patients categorized as having a higher risk of cancer should have been enrolled. However, the main goal of this study was to demonstrate superior lesion detectability of LCI in comparison to that achieved with WLI. Therefore, diminutive lesions, which are more difficult to detect than large polyps, should be an appropriate study object to prove lesion detection ability. Moreover, we believe that lesion detection during insertion is clinically very important, decreasing risk of a missed lesion located in the sigmoid colon; however, there is paucity of supporting literature. Further research is needed to provide sufficient evidence of the importance of insertion-phase imaging during routine colonoscopy.

Conclusion
==========

In conclusion, this study showed that use of LCI during the insertion phase of colonoscopy contributes to better detection of lesions in the sigmoid colon than that achieved with conventional colonoscopy with WLI. In addition, there are some lesions that can only be detected during insertion, especially in sigmoid colon, due to its anatomical features and practical clinical features.
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